ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 1000

Use of Mutual Information Theory in Development and Refinement of a Predictive Model for Early Identification of Ankylosing Spondylitis

Atul A. Deodhar1, Cody Garges2, Oodaye Shukla2, Theresa Arndt2, Tara Grabowsky2 and Yujin Park3, 1Oregon Health & Science University, Portland, OR, 2HVH Precision Analytics, LLC, King of Prussia, PA, 3Novartis Pharmaceuticals Corporation, East Hanover, NJ

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: administrative databases, Ankylosing spondylitis (AS), diagnosis and epidemiologic methods

  • Tweet
  • Email
  • Print
Save to PDF
Session Information

Date: Monday, November 6, 2017

Session Title: Epidemiology and Public Health Poster II: Rheumatic Diseases Other than Rheumatoid Arthritis

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Delayed diagnosis and treatment of ankylosing spondylitis (AS) contribute to the economic, physical and psychological burden on patients and their caregivers. The objective of this analysis was to refine a previously developed predictive mathematical model for AS1 based on features observed in the medical histories of patients with and without a diagnosis of AS to aid in the earlier identification of AS.

Methods: This retrospective cohort study used administrative claims data from > 182 million patients in the Truven Health MarketScan® Commercial and Medicare Supplemental Databases from January 2006 to September 2015 (Segment 1) and October 2015 to November 2016 (Segment 2). The AS population in Segment 1 included all patients with ≥ 2 diagnoses of AS (ICD-9-CM 720.0) by rheumatologists ≥ 30 days apart who had ≥ 12 months of continuous enrollment prior to first AS diagnosis. Control patients were matched by age, sex, enrollment period and geographic location and were randomly selected from the same database. Mutual information was used to identify features that differentiated AS from the control population; select features were then used as inputs in development of a suite of predictive models using data from Segment 1.1 The optimized predictive model was then tested by observing whether patients predicted to have AS in Segment 1 subsequently received an ICD-10-CM AS diagnosis code (M45.x or M08.1) in Segment 2.

Results: In the initial study, 3 iterations of the predictive risk model (Models 1, 2 and 3a/3b) were developed using data from patients with ≥ 1 ICD-9-CM AS diagnosis during Segment 1, with each subsequent model iteration using additional AS-specific queries to reflect a more real-world situation.1 A 2-stage model (Models 4 and 5) was built using patients with ≥ 2 ICD-9-CM AS diagnoses during Segment 1 to improve performance. Model 4 identified patients with AS from the general control population in the database (Figure 1A). To further improve precision, Model 5 was built using 50,000 random patients in Segment 1 who scored above a 0.5 in Model 4 (i.e., were more like patients with AS) as a new control population (Figure 1B). Models 4 and 5 were then combined to identify new patients with AS in Segment 2; of the ≈ 20 million patients who tracked across Segment 1 and Segment 2, 742 patients had an ICD-10-CM AS diagnosis in Segment 2 who did not have an ICD-9-CM diagnosis in Segment 1.

Conclusion: Predictive models for AS diagnosis were developed and refined in this US administrative claims database. Work is ongoing to compare the sensitivity and positive predictive value of these predictive models versus more traditional linear regression models, and future research will validate the model in a separate, commercially insured population database.

Reference:

1.)   Garges C, et al. Presented at the ISPOR 22nd Annual International Meeting; May 20-24, 2017; Boston, MA; [Poster PRM85].


Disclosure: A. A. Deodhar, Eli Lilly, GSK, Janssen, Novartis, Pfizer, Sun Pharma and UCB, 2,AbbVie, Eli Lilly, Janssen, Novartis, Pfizer and UCB, 9; C. Garges, HVH Precision Analytics, LLC, 3; O. Shukla, HVH Precision Analytics, LLC, 3; T. Arndt, HVH Precision Analytics, LLC, 3; T. Grabowsky, HVH Precision Analytics, LLC, 3; Y. Park, Novartis Pharmaceuticals Corporation, 3.

To cite this abstract in AMA style:

Deodhar AA, Garges C, Shukla O, Arndt T, Grabowsky T, Park Y. Use of Mutual Information Theory in Development and Refinement of a Predictive Model for Early Identification of Ankylosing Spondylitis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/use-of-mutual-information-theory-in-development-and-refinement-of-a-predictive-model-for-early-identification-of-ankylosing-spondylitis/. Accessed March 7, 2021.
  • Tweet
  • Email
  • Print
Save to PDF

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/use-of-mutual-information-theory-in-development-and-refinement-of-a-predictive-model-for-early-identification-of-ankylosing-spondylitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.